A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis

Εργασίες Ελλήνων ιατρών

Background
Front-line therapy with mycophenolate mofetil (MMF) in autoimmune hepatitis (AIH) has shown high on-treatment remission rates.

Για να δείτε τη συνέχεια πιέστε εδώ